Chacko Jacob
SEC-identified person · CIK 1608936 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| 4D Molecular Therapeutics, Inc. FMDT | Director | filed 2020 - 2026 |
| Oric Pharmaceuticals, Inc. ORIC | Director · President and CEO | filed 2020 - 2026 |
| Turning Point Therapeutics, Inc. TPTX | Director | filed 2019 - 2020 |
| Ignyta, Inc. RXDX | Chief Financial Officer | filed 2014 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.